Abstract

Rhein is one of active anthraquinone components in traditional Chinese herbal medicine Rheum palmatum L., possessing anti-inflammatory, antioxidant, antitumor, antiviral, and hepatoprotective activities. Human respiratory syncytial virus (RSV), a common virus, is able to result in pneumonia and bronchitis, which usually can be seen in infants. However, so far the effects of Rhein on RSV-induced pneumonia are still unknown. As the NLRP3 inflammasome is activated excessively, it is able to lead to inflammatory response and tissue injury in most viral infection process (including RSV infection) of respiratory tract. Therefore, we designed experiments to reveal whether Rhein can treat RSV-induced pneumonia by inhibiting NLRP3 inflammasome activation. In present research, we established the pneumonia model of BALB/C mice caused by RSV. First of all, the pathology of lung tissue and the weight of mice were evaluated, and the corresponding lung index was calculated. Additionally, the expression of pro-inflammatory mediators in serum and lung tissues, and related proteins (NLRP3, ASC and Caspase-1) of NLRP3 inflammasome and NF-κB pathway were detected by Enzyme-linked immunosorbent assay (ELISA), Real-time PCR (RT-PCR), Immunohistochemistry (IHC), and Western blot (WB), respectively. The determination of lung index and lung tissue pathological evaluation revealed that Rhein was able to alleviate lung infection and injury caused by RSV. The results of ELISA showed that Rhein was able to reduce the release of pro-inflammatory cytokines in the serum and lung tissues of RSV-induced BALB/c mice, including IL-1β, IL-6, TNF-α, IL-18, and IL-33. Additionally, it was revealed that Rhein inhibited the immune inflammatory response of RSV-infected mice, which was likely to be associated with the inhibition the NLRP3 inflammasome activation via NF-κB pathway. To sum up, our results indicated that Rhein may inhibit RSV-induced pulmonary inflammatory response effectively; meanwhile, it is emphasized that Rhein therapy is likely to be a promising treatment on the RSV-infected lung inflammation and avoidance of lung tissue damage.

Highlights

  • As a major reason of respiratory infection of infants and children, human respiratory syncytial virus (RSV) infection is one of the main clinical symptoms of pneumonia and bronchiolitis (Aranda and Polack, 2019)

  • The results showed that Rhein was able to alleviate RSV-induced pneumonia

  • The control group’s lung index of mice was obviously below the RSV-induced group as demonstrated in Figure 2B; it showed that it was successful to make the model of pneumonia caused by RSV

Read more

Summary

Introduction

As a major reason of respiratory infection of infants and children, human respiratory syncytial virus (RSV) infection is one of the main clinical symptoms of pneumonia and bronchiolitis (Aranda and Polack, 2019). Lung histopathology and inflammation are not able to be improved by the antibody (Olszewska et al, 2011). Ribavirin is given the permission to treat virus infection extensively, including all infants and immunocompromised patients with serious infection with RSV. The effectiveness of ribavirin is extremely limited, and it has more additional side effects. It may cause hemolytic anemia (Krilov, 2011; Mooney et al, 2014).

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call